• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

春季角结膜炎:过敏和自身免疫。

Vernal keratoconjunctivitis: atopy and autoimmunity.

机构信息

Department of Pediatrics, Sapienza University of Rome, Rome, Italy.

出版信息

Eur Rev Med Pharmacol Sci. 2013 May;17(10):1419-23.

PMID:23740459
Abstract

BACKGROUND

Vernal Keratoconjunctivitis (VKC) is a rare chronic ocular inflammatory disease and it mainly affects boys in the first decade of life. Although it is a self-limiting disease, patients may present many phases characterized by an exacerbation of inflammatory symptoms with a consequent decline of the quality of life.

PURPOSE

define the clinical and immunological profile of patients affected by VKC and investigate their familiar history of autoimmune disorders and their autoimmunity pattern.

PATIENTS AND METHODS

28 children were enrolled (20 males, 71%) aged between 4 and 14 years of life affected by VKC. Family history of allergic and immunological diseases was collected for each patient. In particular, it was asked whether some components of their families were affected by Hashimoto's thyroiditis, type I diabetes, psoriasis or rheumatoid arthritis and Systemic Lupus Erythematosus (SLE). All VKC children underwent a serological evaluation of anti-nuclear antibodies (ANA).

RESULTS

A family history of immunological disorders was found in 46% of patients, 28% of Hashimoto's thyroiditis, 14% of type I diabetes, 14% of psoriasis, and 1 of Systemic Lupus Erythematosus. Furthermore, 35% of patients was ANA positive and they corresponded to patients with a higher ocular score and with the most important clinical symptoms.

CONCLUSIONS

the detection of ANA positivity and of a familiar history of autoimmune disorders in a high percentage of children with VKC may help us to better understand the association of this ocular inflammatory disease with systemic autoimmune disorders and atopic condition.

摘要

背景

春季角结膜炎(VKC)是一种罕见的慢性眼部炎症性疾病,主要影响生命的第一个十年中的男孩。尽管它是一种自限性疾病,但患者可能会出现许多阶段,其特征是炎症症状加重,导致生活质量下降。

目的

定义受 VKC 影响的患者的临床和免疫学特征,并研究他们自身免疫性疾病的家族史及其自身免疫模式。

患者和方法

共纳入 28 名(20 名男性,71%)4 至 14 岁患有 VKC 的儿童。为每位患者收集了过敏和免疫病史家族史。特别是,询问他们的家庭成员是否有桥本甲状腺炎、1 型糖尿病、银屑病或类风湿关节炎和系统性红斑狼疮(SLE)的一些成分。所有 VKC 儿童均接受抗核抗体(ANA)的血清学评估。

结果

46%的患者有免疫性疾病家族史,28%的患者有桥本甲状腺炎,14%的患者有 1 型糖尿病,14%的患者有银屑病,1 例系统性红斑狼疮。此外,35%的患者 ANA 阳性,他们对应于眼部评分较高和具有最重要临床症状的患者。

结论

在患有 VKC 的儿童中,ANA 阳性和自身免疫性疾病家族史的检出率较高,这可能有助于我们更好地理解这种眼部炎症性疾病与全身性自身免疫性疾病和特应性条件的关联。

相似文献

1
Vernal keratoconjunctivitis: atopy and autoimmunity.春季角结膜炎:过敏和自身免疫。
Eur Rev Med Pharmacol Sci. 2013 May;17(10):1419-23.
2
New insights into childhood Vernal keratoconjunctivitis-associated factors.对儿童春季角结膜炎相关因素的新认识。
Pediatr Allergy Immunol. 2012 Nov;23(7):682-5. doi: 10.1111/j.1399-3038.2012.01281.x. Epub 2012 Sep 11.
3
High-mobility group box-1 (HMGB-1) and serum soluble receptor for advanced glycation end products (sRAGE) in children affected by vernal keratoconjunctivitis.高迁移率族蛋白盒1(HMGB-1)与春季角结膜炎患儿血清晚期糖基化终产物可溶性受体(sRAGE)
Pediatr Allergy Immunol. 2014 Feb;25(1):57-63. doi: 10.1111/pai.12142. Epub 2013 Nov 17.
4
Pathogenesis of Vernal Keratoconjunctivitis and Associated Factors.春季角结膜炎的发病机制及相关因素
Semin Ophthalmol. 2015;30(5-6):340-4. doi: 10.3109/08820538.2013.874483. Epub 2014 Feb 27.
5
[Hashimoto's thyroiditis and autoimmunity parameters: descriptive study].[桥本甲状腺炎与自身免疫参数:描述性研究]
Minerva Med. 2007 Apr;98(2):95-9.
6
Prospective, multicenter demographic and epidemiological study on vernal keratoconjunctivitis: a glimpse of ocular surface in Italian population.春季角结膜炎的前瞻性、多中心人口统计学和流行病学研究:意大利人群眼表一瞥
Ophthalmic Epidemiol. 2009 Jan-Feb;16(1):38-41. doi: 10.1080/09286580802573177.
7
Acquisition of vernal and atopic keratoconjunctivitis after bone marrow transplantation.骨髓移植后获得性春季角结膜炎和特应性角结膜炎
Am J Ophthalmol. 2008 Sep;146(3):462-5. doi: 10.1016/j.ajo.2008.05.012. Epub 2008 Jul 9.
8
Vernal keratoconjunctivitis-like disease in adults.成人春季角结膜炎样疾病。
Am J Ophthalmol. 2013 May;155(5):796-803. doi: 10.1016/j.ajo.2012.11.018. Epub 2013 Jan 23.
9
The differences of tear function and ocular surface findings in patients with atopic keratoconjunctivitis and vernal keratoconjunctivitis.特应性角结膜炎和春季角结膜炎患者泪液功能及眼表表现的差异
Allergy. 2007 Aug;62(8):917-25. doi: 10.1111/j.1398-9995.2007.01414.x.
10
[Immunological and clinical features of vernal keratoconjunctivitis between persons with and without systemic atopic dermatitis].[全身性特应性皮炎患者与非全身性特应性皮炎患者春季角结膜炎的免疫学及临床特征]
Nippon Ganka Gakkai Zasshi. 2000 Sep;104(9):638-43.

引用本文的文献

1
Ocular Manifestations in Children with Vernal Keratoconjunctivitis.春季角结膜炎患儿的眼部表现
Children (Basel). 2025 May 7;12(5):609. doi: 10.3390/children12050609.
2
Seeing eye to eye: a modified Delphi method-based multidisciplinary expert consensus on the diagnosis and treatment of vernal keratoconjunctivitis.意见一致:基于改良 Delphi 法的多学科专家对春季角结膜炎诊断和治疗的共识。
Eur J Pediatr. 2024 Nov;183(11):5053-5061. doi: 10.1007/s00431-024-05776-0. Epub 2024 Sep 26.
3
A Case of Refractory Vernal Keratoconjunctivitis Showing Improvement after the Administration of Upadacitinib for the Treatment of Atopic Dermatitis.
1例难治性春季角结膜炎在使用乌帕替尼治疗特应性皮炎后病情改善
Diagnostics (Basel). 2024 Jun 17;14(12):1272. doi: 10.3390/diagnostics14121272.
4
Novel Insights in the Management of Vernal Keratoconjunctivitis (VKC): European Expert Consensus Using a Modified Nominal Group Technique.春季角结膜炎(VKC)管理的新见解:采用改良名义群体技术的欧洲专家共识
Ophthalmol Ther. 2023 Apr;12(2):1207-1222. doi: 10.1007/s40123-023-00665-5. Epub 2023 Feb 15.
5
Corneal biomechanical properties in vernal keratoconjunctivitis and its subtypes: a preliminary study.春季角结膜炎及其亚型的角膜生物力学特性:初步研究。
Int Ophthalmol. 2023 Jun;43(6):2083-2090. doi: 10.1007/s10792-022-02608-8. Epub 2022 Dec 20.
6
Vernal keratoconjunctivitis: state of art and update on treatment.春季角结膜炎:治疗的现状与更新。
Acta Biomed. 2021 Nov 29;92(S7):e2021517. doi: 10.23750/abm.v92iS7.12419.
7
Understanding Vernal Keratoconjunctivitis: Beyond Allergic Mechanisms.认识春季角结膜炎:超越过敏机制
Life (Basel). 2021 Sep 26;11(10):1012. doi: 10.3390/life11101012.
8
Conjunctivitis: A Systematic Review.结膜炎:一项系统评价
J Ophthalmic Vis Res. 2020 Aug 6;15(3):372-395. doi: 10.18502/jovr.v15i3.7456. eCollection 2020 Jul-Sep.
9
The role of human immunodeficiency virus in the pathogenesis of vernal keratoconjunctivitis-like disease in adults: A demographic and epidemiological study.人类免疫缺陷病毒在成人春季角结膜炎样疾病发病机制中的作用:一项人口统计学和流行病学研究。
Indian J Ophthalmol. 2020 Aug;68(8):1551-1554. doi: 10.4103/ijo.IJO_1608_19.
10
Eye drop emulsion containing 0.1% cyclosporin (1 mg/mL) for the treatment of severe vernal keratoconjunctivitis: an evidence-based review and place in therapy.含0.1%环孢素(1毫克/毫升)的滴眼剂乳剂用于治疗重度春季角结膜炎:循证综述及治疗地位
Clin Ophthalmol. 2019 Jul 5;13:1147-1155. doi: 10.2147/OPTH.S181811. eCollection 2019.